I would hope that any TO would be at a greater premium than that. If it is done of the bais of Cephalon taking up their rights at 70c one would assume the data is good and that FDA approval highly likely. In my mind that should put the SP value at that point at 70 and probably closer to where they were a year ago - any TO should be at a premium to that I would have thought.
Cheers,
I-man
- Forums
- ASX - By Stock
- promising biotech
I would hope that any TO would be at a greater premium than...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online